Article

Catestatin peptide impedes melanoma progression and drug resistance by reprogramming oncogenic signaling pathways

2026-01-19

Abstract excerpt

<title>Abstract</title> <p>Melanoma remains one of the most aggressive and treatment-resistant cancers, emphasizing the need for novel therapeutics. In our current study we report a peptide-based approach as potential therapeutic. Here we report for the first time the involvement of Catestatin (CST) peptide in carcinogenesis, with melanoma identified as unexplored and therapeutically relevant context. The express...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7a3c6ea6-04a8-5a0a-bd51-5418c4bea941
DOI: 10.21203/rs.3.rs-8548714/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Catestatin peptide impedes melanoma progression and drug resistance by reprogramming oncogenic signaling pathwaysDOI 10.21203/rs.3.rs-8548714/v1Read

Catestatin suppresses melanoma progression and drug resistance through multitargeted modulation of signaling pathwaysSemantic proximity Read

Caerin 1.1 and 1.9 peptides halt B16 melanoma metastatic tumours via expanding cDC1 and reprogramming tumour macrophagesSemantic proximity Read

Caerin 1.1 and 1.9 peptides halt B16 melanoma metastatic tumours via expanding cDC1 and reprogramming tumour macrophagesSemantic proximity Read

Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic moleculesSemantic proximity Read

Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T cells in uveal melanoma patientsSemantic proximity Read

The structural conformation of the tachykinin domain drives the anti-tumoural activity of an octopus peptide in melanoma BRAFV600E.Semantic proximity Read

17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model.Semantic proximity Read

Chromomycin A <sub>5</sub> induces bonafide immunogenic cell death in metastatic melanomaSemantic proximity Read

The rise of new targets in melanoma.Semantic proximity Read

The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cellsSemantic proximity Read

Cross-talk between Dopachrome Tautomerase and Caveolin-1 Is Melanoma Cell Phenotype-specific and Potentially Involved in Tumor Progression.Semantic proximity Read

Epigenetic reprogramming of melanoma cells by vitamin C treatmentSemantic proximity Read